Samsung’s ‘Spatial Signage’ Enhances 3D Immersion at Everland’s Horror Attraction
Samsung Applies Proprietary 3D Plate Technology… Enhances 3D Horror Experience
ATEEZ’s Sani, Transformed into a Zombie, Approaches in 3D Interactive Experience
Integrating Facial Recognition and Distance Sensors… Reactive Zombies Heighten the Sense of Fear
[Edaily Reporter SOYEON KIM ] SamsungElectronics announced on the 20th that its next-generation glasses-free 3D display, “Spatial Signage,” has been introduced to Everland’s fall horror-themed zone. SamsungElectronics’ cutting-edge display technology has been integrated into Everland’s unique storytelling-themed zone—operated by SAMSUNG C&T CORPORATION’s Resort Division—to enhance the 3D immersion and intensify the horror experience for visitors.
SamsungElectronics appears to be expanding the scope of display applications into the entertainment and experiential content sectors by leveraging its glasses-free 3D technology. SamsungElectronics’ “Spatial Signage” installed at Everland’s Blood City. San from the group ATEEZ, this year’s promotional model for Everland’s Blood City, makes a bold appearance as a “zombie idol.” (Photo: SamsungElectronics) The Spatial Signage was installed on the 18th at “Blood City Zero,” Everland’s flagship immersive horror theme zone for the fall season. The product incorporates SamsungElectronics’ proprietary “3D Plate” technology. It creates a three-dimensional effect that makes it seem as though another deep space exists within the display screen, without the need for separate 3D glasses or special equipment.
A total of five SamsungElectronics displays have been installed in this media horror experience zone. On the 85-inch Spatial Signage located in the center of the experience zone, San from the group ATEEZ—this year’s promotional model for Everland’s Blood City—appears in a bold “zombie idol” look. SamsungElectronics’ “Spatial Signage” installed at Everland’s Blood City. San from the group ATEEZ, this year’s promotional model for Everland’s Blood City, appears in a bold “zombie idol” look. (Photo: SamsungElectronics) On the Spatial Signage, which features a dedicated touch sensor, when visitors touch San in the video, he—transformed into a “zombie idol”—reaches out toward them through a glasses-free 3D effect. It delivers a vivid and overwhelming sense of depth, as if he were about to break through the screen and leap out.
SamsungElectronics’ Smart Signage displays, positioned on either side of the Spatial Signage, are equipped with separate facial recognition and distance sensors. When a visitor approaches the screen, the sensors detect their presence in real time, triggering responsive video content in crisp 4K resolution that shows a zombie approaching the viewer. This further maximizes the horror experience in the horror-themed zone.
Everland’s Blood City is a horror-themed zone that has gained immense popularity among visitors for its unique world-building and distinctive experiential elements. This year, under the concept of “Blood City Zero,” an immersive horror festival is underway through November 22. Through a collaboration with director Lee Seok-hoon—known for films such as *The Pirates* and *The Outlaws 2*—the park is presenting cinematic horror content, including Korea’s first outdoor immersive horror performance. SamsungElectronics’ “Spatial Signage” installed at Everland’s Blood City. San from the group ATEEZ, this year’s promotional model for Everland’s Blood City, makes a bold appearance as a “zombie idol.” (Photo: SamsungElectronics)
SAMSUNG BIOLOGICS(207940)has announced plans to respond strictly, in accordance with the law and established principles, to any illegal or unlawful acts related to the conflict with the labor union ov…
“‘Jjarur,’ a jajangmyeon-flavored instant noodle made with lard, sold 10 million servings within 100 days of its launch. The company aims to surpass 10 billion won in sales by the end of the year.” (K…
NeoImmuneTech, Inc.(950220)announced on the 7th that its U.S. partner, Tolerance Bio, presented “NT-I7” (epineptakin alfa), a long-acting interleukin-7 (IL-7) candidate, as a key clinical pipeline for…